[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @StockwatchDK Stockwatch DK Stockwatch DK posts on X about target, bank, stocks, outperform the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1955238286718341120/interactions)  - X Week XXX -XX% - X Month XXXXX +30% ### Mentions: XX [#](/creator/twitter::1955238286718341120/posts_active)  - X Week XX -XX% - X Month XXX +21% ### Followers: XX [#](/creator/twitter::1955238286718341120/followers)  - X Week XX +6.70% - X Month XX +14% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1955238286718341120/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) XXXXX% [currencies](/list/currencies) XX% [stocks](/list/stocks) XXXX% [countries](/list/countries) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [target](/topic/target) 18.57%, [bank](/topic/bank) 4.29%, [stocks](/topic/stocks) 4.29%, [outperform](/topic/outperform) #24, [$hsbc](/topic/$hsbc) 2.86%, [business](/topic/business) 2.86%, [reduce](/topic/reduce) 1.43%, [oslo](/topic/oslo) 1.43%, [novo](/topic/novo) 1.43%, [acquisition](/topic/acquisition) XXXX% **Top assets mentioned** [HSBC Holdings PLC (HSBC)](/topic/$hsbc) [Citigroup Inc (C)](/topic/citigroup) ### Top Social Posts Top posts by engagements in the last XX hours "Citi changes its top pick in the Nordic banking sector to Danske Bank from Nordea but maintains its Buy recommendations on both stocks. See comments" [X Link](https://x.com/StockwatchDK/status/1998313976938086666) 2025-12-09T08:49Z XX followers, XX engagements "Kepler Cheuvreux upgrades Vestas Wind Systems to Buy from Reduce and hikes the target price to DKK XXX from DKK XXX as the analyst has made a reassessment of the risks and earning capacity. See comments" [X Link](https://x.com/StockwatchDK/status/1998665569097437677) 2025-12-10T08:06Z XX followers, XX engagements "Demant receives an "overweight" rating from J.P. Morgan with analysts viewing FY25 guidance as tight but seeing an improved setup into FY26 at 16x FY26 price-to-earnings ratio. See comments" [X Link](https://x.com/StockwatchDK/status/1998679930758955030) 2025-12-10T09:03Z XX followers, XX engagements "Bernstein Research has maintained its Outperform rating on Vestas with a price target of XXX Danish kroner. European energy companies have much to offer in 2026 wrote Deepa Venkateswaran. See comments" [X Link](https://x.com/StockwatchDK/status/1999417760334369242) 2025-12-12T09:55Z XX followers, XX engagements "DNB Carnegie's Nordic Healthcare Conference 2025 has kicked off in Oslo with Danish participants Gubra Embla Medical Genmab ALK Ambu Coloplast Zealand Pharma Novo Nordisk and Lundbeck" [X Link](https://x.com/StockwatchDK/status/1993240030161322104) 2025-11-25T08:47Z XX followers, XXX engagements "ABGSC has identified a group of potential acquisition candidates using LBO and bottom-up screening. XX candidates have been identified among those are two Danish companies: GN Store Nord and Trifork" [X Link](https://x.com/StockwatchDK/status/1993308036933558773) 2025-11-25T13:17Z XX followers, XX engagements "Citigroup reiterates its Buy rating on GN Store Nord with a target price of DKK XXX after a meeting with the company's IR manager Rune Sandager. See comments" [X Link](https://x.com/StockwatchDK/status/1996531836592501151) 2025-12-04T10:47Z XX followers, XX engagements "DNB Carnegie reiterates its Buy recommendation on Zealand Pharma with a price target of DKK XXX per share ahead of the company's Capital Markets Day next Thursday. See comments" [X Link](https://x.com/StockwatchDK/status/1996867392060928136) 2025-12-05T09:01Z XX followers, XX engagements "Leerink Partners raises its price target on Genmab to $XXXXX (DKK2436) from $XXXXX (DKK2179) while maintaining an Outperform rating following positive data presented at the American Society of Hematology (ASH) 2025 Annual Meeting. See comments" [X Link](https://x.com/StockwatchDK/status/1997974837273264396) 2025-12-08T10:21Z XX followers, XX engagements "GN Store Nord receives a "Neutral" rating from J.P. Morgan with shares trading on 12.6x FY26 price-to-earnings ratio. See comments" [X Link](https://x.com/StockwatchDK/status/1998680193490190738) 2025-12-10T09:04Z XX followers, XX engagements "Tariffs destocking US funding risk and China hit European medtech stocks in 2025 but challenges are priced in says Exane BNP Paribas as it picks its favourites in the sector. See comments" [X Link](https://x.com/StockwatchDK/status/1998706955288789278) 2025-12-10T10:50Z XX followers, XX engagements "According to the brokerage re-rating will materialize in the second half of 2026. BNP'a top picks are Essilorluxottica Sartorius Stedim and Fresenius" [X Link](https://x.com/StockwatchDK/status/1998707035400188222) 2025-12-10T10:51Z XX followers, XX engagements "GN Store Nord has its price target lowered to DKK XXX from DKK XXX while the Outperform rating is maintained. Demant also has its target reduced to DKK XXX from DKK XXX and with the Outperform rating unchanged" [X Link](https://x.com/StockwatchDK/status/1998707575555232009) 2025-12-10T10:53Z XX followers, XX engagements "HSBC raises the firms price target on Novo Nordisk to DKK350 from DKK300 and keeps a Hold rating on the shares as part of a 2026 outlook for the pharma group. See more in comments" [X Link](https://x.com/StockwatchDK/status/1998718669979808070) 2025-12-10T11:37Z XX followers, XX engagements "HSBC believes the sector is well positioned to outperform in 2026 even more so if AI panic kicks in. HSBCs preferred stocks are growth bucket ideas but says fallen angels and value could work as well" [X Link](https://x.com/StockwatchDK/status/1998718801815146846) 2025-12-10T11:37Z XX followers, XX engagements "Danske Bank reiterates Buy on Pandora but reduces the target price to DKK980 from DKK1050 due to lowering of profit estimates on adjustments to the silver price. See comments" [X Link](https://x.com/StockwatchDK/status/1999046644986524075) 2025-12-11T09:20Z XX followers, XX engagements "Zealand Pharma today announced an agreement with Chinese biotech firm OTR Therapeutics to develop oral small molecule treatments for metabolic diseases. UBS calls the partnership an interesting move. See comments" [X Link](https://x.com/StockwatchDK/status/1999103948536283576) 2025-12-11T13:08Z XX followers, XX engagements "She pointed to the priced-in industry discount expected annual profit increases and higher dividend yields. The analyst favors electricity grid operators but also sees opportunities in the renewable energy sector explicitly mentioning EDP Renovveis RWE and Engie" [X Link](https://x.com/StockwatchDK/status/1999417820208402435) 2025-12-12T09:55Z XX followers, XX engagements "JPMorgan analyst Javier Garrido reinstated coverage of Orsted/rsted with a Neutral rating and DKK XXX price target. The firm sees a balanced risk/reward at current share levels" [X Link](https://x.com/StockwatchDK/status/1999418663443853416) 2025-12-12T09:58Z XX followers, XX engagements "ABG Sundal Collier upgrades FLSmidth to Buy from Hold and hikes the target price to DKK XXX from DKK XXX pointing to upcoming stronger financials and margin expansion. See comments" [X Link](https://x.com/StockwatchDK/status/1999421773943906505) 2025-12-12T10:11Z XX followers, XX engagements "Novo CFO Karsten Munk Knudsen said the company will focus on the launch of the Wegovy pill next year. Novo expects a U.S. approval of the pill before year-end and thereafter Novo expects to launch it within a few weeks" [X Link](https://x.com/StockwatchDK/status/1996865553219363124) 2025-12-05T08:53Z XX followers, XX engagements "Berenberg expects Novo to deliver negative revenue growth of X percent next year and negative earnings per share growth of X percent" [X Link](https://x.com/StockwatchDK/status/1996866058838524110) 2025-12-05T08:55Z XX followers, XX engagements "Danske Bank lifts its 12-month target price on Vestas to DKK210 from DKK180 and reiterate the Buy recommendation. See comments" [X Link](https://x.com/StockwatchDK/status/1999033057903301062) 2025-12-11T08:26Z XX followers, XX engagements "Danske says: As we approach the end of 2025 we now look a year further ahead and base our valuation on 2027 estimates instead of 2026" [X Link](https://x.com/StockwatchDK/status/1999033107140456689) 2025-12-11T08:26Z XX followers, X engagements "Danske argues that Vestas is becoming less of a green transition case as its customers are increasingly generation-source-atheists that want power regardless of the source" [X Link](https://x.com/StockwatchDK/status/1999033254251577597) 2025-12-11T08:27Z XX followers, XX engagements "Says: In combination with a very substantial increase in expected power demand in both Europe and North America we see attractive market conditions ahead and reiterate our Buy recommendation" [X Link](https://x.com/StockwatchDK/status/1999033309226037326) 2025-12-11T08:27Z XX followers, XX engagements "SEB reiterates its Buy recommendation on Novo Nordisk but reduces the target price to DKK XXX from XXX as the analysts revise their estimates to reflect current pricing dynamics and script trends. See comments" [X Link](https://x.com/StockwatchDK/status/1999034833750884359) 2025-12-11T08:33Z XX followers, XX engagements "Says: Our estimates align with the midpoint of Aarsleff's guidance pointing to an EBIT margin of 5.1%. For 2025/26 we see further profitability upside driven by improvements in the Ground Engineering segment" [X Link](https://x.com/StockwatchDK/status/1999039835474968612) 2025-12-11T08:53Z XX followers, XX engagements "Says: While we cannot dismiss risks to parts of Novo Nordisk's capex plans particularly for projects that do not have shovels in the ground we maintain a positive attitude towards the market backdrop and we continue to see significant business opportunities for Aarsleff" [X Link](https://x.com/StockwatchDK/status/1999039920589910392) 2025-12-11T08:53Z XX followers, XX engagements "Nordea bakes in the Bgelund VVS and Styrud additions thus hiking the target price" [X Link](https://x.com/StockwatchDK/status/1999040040719323524) 2025-12-11T08:54Z XX followers, XX engagements "ABG analyst Mikkel Lgsted anticipates around XX% organic order growth in FY 2026 supported by a XX% year-on-year increase in metal prices. The analyst notes the stock still trades at a slightly higher than historical discount to peers" [X Link](https://x.com/StockwatchDK/status/1999421866889609706) 2025-12-12T10:11Z XX followers, XX engagements "Lgsted adds that the upcoming departure of CEO Mikko Keto marks the end of the company's successful restructuring. But with a cleaner business mix stronger financials and margin expansion ahead combined with a XX% EPS CAGR(2025-2027) ABG upgrades its recommendation to Buy" [X Link](https://x.com/StockwatchDK/status/1999422096074768398) 2025-12-12T10:12Z XX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@StockwatchDK Stockwatch DK
Stockwatch DK posts on X about target, bank, stocks, outperform the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX -XX%
- X Month XXXXX +30%
Mentions: XX #
- X Week XX -XX%
- X Month XXX +21%
Followers: XX #
- X Week XX +6.70%
- X Month XX +14%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence finance XXXXX% currencies XX% stocks XXXX% countries XXXX% travel destinations XXXX%
Social topic influence target 18.57%, bank 4.29%, stocks 4.29%, outperform #24, $hsbc 2.86%, business 2.86%, reduce 1.43%, oslo 1.43%, novo 1.43%, acquisition XXXX%
Top assets mentioned HSBC Holdings PLC (HSBC) Citigroup Inc (C)
Top Social Posts
Top posts by engagements in the last XX hours
"Citi changes its top pick in the Nordic banking sector to Danske Bank from Nordea but maintains its Buy recommendations on both stocks. See comments"
X Link 2025-12-09T08:49Z XX followers, XX engagements
"Kepler Cheuvreux upgrades Vestas Wind Systems to Buy from Reduce and hikes the target price to DKK XXX from DKK XXX as the analyst has made a reassessment of the risks and earning capacity. See comments"
X Link 2025-12-10T08:06Z XX followers, XX engagements
"Demant receives an "overweight" rating from J.P. Morgan with analysts viewing FY25 guidance as tight but seeing an improved setup into FY26 at 16x FY26 price-to-earnings ratio. See comments"
X Link 2025-12-10T09:03Z XX followers, XX engagements
"Bernstein Research has maintained its Outperform rating on Vestas with a price target of XXX Danish kroner. European energy companies have much to offer in 2026 wrote Deepa Venkateswaran. See comments"
X Link 2025-12-12T09:55Z XX followers, XX engagements
"DNB Carnegie's Nordic Healthcare Conference 2025 has kicked off in Oslo with Danish participants Gubra Embla Medical Genmab ALK Ambu Coloplast Zealand Pharma Novo Nordisk and Lundbeck"
X Link 2025-11-25T08:47Z XX followers, XXX engagements
"ABGSC has identified a group of potential acquisition candidates using LBO and bottom-up screening. XX candidates have been identified among those are two Danish companies: GN Store Nord and Trifork"
X Link 2025-11-25T13:17Z XX followers, XX engagements
"Citigroup reiterates its Buy rating on GN Store Nord with a target price of DKK XXX after a meeting with the company's IR manager Rune Sandager. See comments"
X Link 2025-12-04T10:47Z XX followers, XX engagements
"DNB Carnegie reiterates its Buy recommendation on Zealand Pharma with a price target of DKK XXX per share ahead of the company's Capital Markets Day next Thursday. See comments"
X Link 2025-12-05T09:01Z XX followers, XX engagements
"Leerink Partners raises its price target on Genmab to $XXXXX (DKK2436) from $XXXXX (DKK2179) while maintaining an Outperform rating following positive data presented at the American Society of Hematology (ASH) 2025 Annual Meeting. See comments"
X Link 2025-12-08T10:21Z XX followers, XX engagements
"GN Store Nord receives a "Neutral" rating from J.P. Morgan with shares trading on 12.6x FY26 price-to-earnings ratio. See comments"
X Link 2025-12-10T09:04Z XX followers, XX engagements
"Tariffs destocking US funding risk and China hit European medtech stocks in 2025 but challenges are priced in says Exane BNP Paribas as it picks its favourites in the sector. See comments"
X Link 2025-12-10T10:50Z XX followers, XX engagements
"According to the brokerage re-rating will materialize in the second half of 2026. BNP'a top picks are Essilorluxottica Sartorius Stedim and Fresenius"
X Link 2025-12-10T10:51Z XX followers, XX engagements
"GN Store Nord has its price target lowered to DKK XXX from DKK XXX while the Outperform rating is maintained. Demant also has its target reduced to DKK XXX from DKK XXX and with the Outperform rating unchanged"
X Link 2025-12-10T10:53Z XX followers, XX engagements
"HSBC raises the firms price target on Novo Nordisk to DKK350 from DKK300 and keeps a Hold rating on the shares as part of a 2026 outlook for the pharma group. See more in comments"
X Link 2025-12-10T11:37Z XX followers, XX engagements
"HSBC believes the sector is well positioned to outperform in 2026 even more so if AI panic kicks in. HSBCs preferred stocks are growth bucket ideas but says fallen angels and value could work as well"
X Link 2025-12-10T11:37Z XX followers, XX engagements
"Danske Bank reiterates Buy on Pandora but reduces the target price to DKK980 from DKK1050 due to lowering of profit estimates on adjustments to the silver price. See comments"
X Link 2025-12-11T09:20Z XX followers, XX engagements
"Zealand Pharma today announced an agreement with Chinese biotech firm OTR Therapeutics to develop oral small molecule treatments for metabolic diseases. UBS calls the partnership an interesting move. See comments"
X Link 2025-12-11T13:08Z XX followers, XX engagements
"She pointed to the priced-in industry discount expected annual profit increases and higher dividend yields. The analyst favors electricity grid operators but also sees opportunities in the renewable energy sector explicitly mentioning EDP Renovveis RWE and Engie"
X Link 2025-12-12T09:55Z XX followers, XX engagements
"JPMorgan analyst Javier Garrido reinstated coverage of Orsted/rsted with a Neutral rating and DKK XXX price target. The firm sees a balanced risk/reward at current share levels"
X Link 2025-12-12T09:58Z XX followers, XX engagements
"ABG Sundal Collier upgrades FLSmidth to Buy from Hold and hikes the target price to DKK XXX from DKK XXX pointing to upcoming stronger financials and margin expansion. See comments"
X Link 2025-12-12T10:11Z XX followers, XX engagements
"Novo CFO Karsten Munk Knudsen said the company will focus on the launch of the Wegovy pill next year. Novo expects a U.S. approval of the pill before year-end and thereafter Novo expects to launch it within a few weeks"
X Link 2025-12-05T08:53Z XX followers, XX engagements
"Berenberg expects Novo to deliver negative revenue growth of X percent next year and negative earnings per share growth of X percent"
X Link 2025-12-05T08:55Z XX followers, XX engagements
"Danske Bank lifts its 12-month target price on Vestas to DKK210 from DKK180 and reiterate the Buy recommendation. See comments"
X Link 2025-12-11T08:26Z XX followers, XX engagements
"Danske says: As we approach the end of 2025 we now look a year further ahead and base our valuation on 2027 estimates instead of 2026"
X Link 2025-12-11T08:26Z XX followers, X engagements
"Danske argues that Vestas is becoming less of a green transition case as its customers are increasingly generation-source-atheists that want power regardless of the source"
X Link 2025-12-11T08:27Z XX followers, XX engagements
"Says: In combination with a very substantial increase in expected power demand in both Europe and North America we see attractive market conditions ahead and reiterate our Buy recommendation"
X Link 2025-12-11T08:27Z XX followers, XX engagements
"SEB reiterates its Buy recommendation on Novo Nordisk but reduces the target price to DKK XXX from XXX as the analysts revise their estimates to reflect current pricing dynamics and script trends. See comments"
X Link 2025-12-11T08:33Z XX followers, XX engagements
"Says: Our estimates align with the midpoint of Aarsleff's guidance pointing to an EBIT margin of 5.1%. For 2025/26 we see further profitability upside driven by improvements in the Ground Engineering segment"
X Link 2025-12-11T08:53Z XX followers, XX engagements
"Says: While we cannot dismiss risks to parts of Novo Nordisk's capex plans particularly for projects that do not have shovels in the ground we maintain a positive attitude towards the market backdrop and we continue to see significant business opportunities for Aarsleff"
X Link 2025-12-11T08:53Z XX followers, XX engagements
"Nordea bakes in the Bgelund VVS and Styrud additions thus hiking the target price"
X Link 2025-12-11T08:54Z XX followers, XX engagements
"ABG analyst Mikkel Lgsted anticipates around XX% organic order growth in FY 2026 supported by a XX% year-on-year increase in metal prices. The analyst notes the stock still trades at a slightly higher than historical discount to peers"
X Link 2025-12-12T10:11Z XX followers, XX engagements
"Lgsted adds that the upcoming departure of CEO Mikko Keto marks the end of the company's successful restructuring. But with a cleaner business mix stronger financials and margin expansion ahead combined with a XX% EPS CAGR(2025-2027) ABG upgrades its recommendation to Buy"
X Link 2025-12-12T10:12Z XX followers, XX engagements